| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/09/2013 | CA2598353C Non-fibrous transdermal therapeutic system and method for its production |
| 07/09/2013 | CA2597956C Transmucosal administration of drug compositions for treating and preventing disorders in animals |
| 07/09/2013 | CA2588823C Silver treated phosphorylated cotton product |
| 07/09/2013 | CA2566931C Tablets exhibiting reduced drug release variability |
| 07/09/2013 | CA2566343C Nutritional composition for increasing creatine uptake in skeletal muscle |
| 07/09/2013 | CA2563739C Bioavailable solid dosage forms of metaxalone |
| 07/09/2013 | CA2537290C Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
| 07/09/2013 | CA2533314C Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions |
| 07/09/2013 | CA2512824C Improved oral delivery of peptides |
| 07/04/2013 | WO2013102060A1 Compositions containing a silicon resin and a tackifying agent |
| 07/04/2013 | WO2013102034A1 Implantable devices and methods for the evaluation of active agent |
| 07/04/2013 | WO2013102013A1 Aqueous-based personal care product formula that combines friction-controlled fragrance encapsulation technology with a film forming compound to improve adherence of capsules on keratinous surfaces |
| 07/04/2013 | WO2013101887A2 Microcapsules |
| 07/04/2013 | WO2013101884A1 Filled incise drape |
| 07/04/2013 | WO2013101810A1 Formulations of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetyl aminoisoindoline-1,3-dione |
| 07/04/2013 | WO2013101749A1 Stabilized glucagon nanoemulsions |
| 07/04/2013 | WO2013101712A1 Degradable composite materials and uses |
| 07/04/2013 | WO2013101550A1 Solid compositions comprising an hcv inhibitor |
| 07/04/2013 | WO2013100882A2 Combinations of diacerein and non-steroidal inflammation drugs |
| 07/04/2013 | WO2013100881A2 Combined pharmaceutical formulation containing diacerein |
| 07/04/2013 | WO2013100880A1 Formulations comprising cefuroxime |
| 07/04/2013 | WO2013100879A1 Pharmaceutical compositions comprising quetiapine |
| 07/04/2013 | WO2013100878A1 Pharmaceutical formulations comprising aripiprazole |
| 07/04/2013 | WO2013100877A1 Dexketoprofen formulations |
| 07/04/2013 | WO2013100876A1 Risperidone formulations |
| 07/04/2013 | WO2013100874A1 Effervescent pregablin formulation |
| 07/04/2013 | WO2013100873A1 Pharmaceutical formulation of pregabalin (particle size 300-2500 micrometer) |
| 07/04/2013 | WO2013100871A1 Effervescent rivastigmine formulations |
| 07/04/2013 | WO2013100870A1 New antipsychotic compositions |
| 07/04/2013 | WO2013100705A1 Fast-disintegrating tablet suitable for environmentally sensitive drug and process for manufacturing the same |
| 07/04/2013 | WO2013100701A1 Highly robust fast-disintegrating tablet and process for manufacturing the same |
| 07/04/2013 | WO2013100630A1 Fixed dose combination formulation comprising losartan, amlodipine and hydrochlorothiazide |
| 07/04/2013 | WO2013098842A2 Novel film coating composition |
| 07/04/2013 | WO2013098841A1 Nanodispersion of poorly water soluble drug(s) |
| 07/04/2013 | WO2013098675A1 Compositions for the treatment of mucous membrane diseases |
| 07/04/2013 | WO2013098578A1 Immediate release pharmaceutical composition of valsartan hydrochlorothiazide |
| 07/04/2013 | WO2013098577A1 Pharmaceutical compositions of bosentan |
| 07/04/2013 | WO2013098576A1 Immediate release pharmaceutical composition of valsartan |
| 07/04/2013 | WO2013098406A1 Formulations of eprotirome |
| 07/04/2013 | WO2013098402A1 Pharmaceutical combination of fingolimod and nabiximols |
| 07/04/2013 | WO2013098399A1 Mozavaptan formulations |
| 07/04/2013 | WO2013098268A2 Tablets and dry-coated agents |
| 07/04/2013 | WO2013097074A1 Enhancing transdermal delivery of pde-5 inhibitor |
| 07/04/2013 | WO2013057569A3 Extended release pharmaceutical composition containing amoxicillin and clavulanic acid |
| 07/04/2013 | WO2013055073A3 Ophthalmic composition containing cyclosporine and method for preparing same |
| 07/04/2013 | WO2013049106A3 Reduction of implant infection via tunable stimulation of localized adaptive immune response |
| 07/04/2013 | WO2013038195A3 Pharmaceutical nanoparticle compositions |
| 07/04/2013 | WO2013035997A3 Pharmaceutical composition for preventing or treating alopecia comprising tianeptine or its salt |
| 07/04/2013 | WO2013032828A8 Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking |
| 07/04/2013 | WO2013019733A4 Methods, compositions and kits for therapeutic treatment with wet spun microstructures |
| 07/04/2013 | WO2013019669A3 Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses |
| 07/04/2013 | US20130172970 Heat Patch For Obesity |
| 07/04/2013 | US20130172969 Heat patch for tumor |
| 07/04/2013 | US20130172406 Cancer Cell Targeting Using Nanoparticles |
| 07/04/2013 | US20130172392 Solid dispersion preparation |
| 07/04/2013 | US20130172382 Abuse-resistant controlled-release opioid dosage form |
| 07/04/2013 | US20130172374 Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof |
| 07/04/2013 | US20130172357 Compositions and Methods for Treatment of Glaucoma |
| 07/04/2013 | US20130172279 Composition for topical treatment of mixed vaginal infections |
| 07/04/2013 | US20130172268 Drug delivery through hydrogel plugs |
| 07/04/2013 | US20130172255 Compositions and methods for treating joints |
| 07/04/2013 | US20130171298 Novel stable beadlets of lipophilic nutrients |
| 07/04/2013 | US20130171260 Silk microspheres for encapsulation and controlled release |
| 07/04/2013 | US20130171257 Extended release opioid abuse deterrent compositions and methods of making same |
| 07/04/2013 | US20130171256 Alcohol-resistant extended release dosage forms comprising venlafaxine |
| 07/04/2013 | US20130171255 Laxative |
| 07/04/2013 | US20130171254 Fast dissolving pharmaceutical composition comprising lornoxicam |
| 07/04/2013 | US20130171251 Stable pharmaceutical composition and methods of using same |
| 07/04/2013 | US20130171247 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 07/04/2013 | US20130171246 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 07/04/2013 | US20130171241 Liposomes with lipids having an advantageous pka-value for rna delivery |
| 07/04/2013 | US20130171240 Drug carrier and drug carrier kit for inhibiting fibrosis |
| 07/04/2013 | US20130171236 Prevention and Treatment of Ischemia-Reperfusion Injury and Related Conditions |
| 07/04/2013 | US20130171233 Compositions and methods for inducing immune tolerance |
| 07/04/2013 | US20130171232 Heat Patch for Parkinson's Disease |
| 07/04/2013 | US20130171231 Heat Patch For Insomnia |
| 07/04/2013 | US20130171229 Implantable polymeric device for sustained release of buprenorphine |
| 07/04/2013 | US20130171218 Dual function product |
| 07/04/2013 | US20130171207 Micelle encapsulation of a combination of therapeutic agents |
| 07/04/2013 | US20130171206 Method for treating or preventing renal or liver disease |
| 07/04/2013 | US20130171205 Nanocell Drug Delivery System |
| 07/04/2013 | US20130171204 Soft food composition with probiotics and prebiotics for masking medications |
| 07/04/2013 | US20130171202 Antipsychotic Injectable Depot Composition |
| 07/04/2013 | US20130171200 Heat Patch for Diabetes |
| 07/04/2013 | US20130171199 Controlled release pharmaceutical composition |
| 07/04/2013 | US20130171198 Antimicrobial and vulnerary action pharmaceutical composition for external application and its production process |
| 07/04/2013 | US20130171197 Hyaluronic acid hydrogel and use thereof |
| 07/04/2013 | US20130171091 Nanocell Drug Delivery System |
| 07/04/2013 | US20130171075 Abuse-proofed dosage form |
| 07/04/2013 | US20130167838 Nasal formulation |
| 07/04/2013 | CA2857347A1 Composition and method for compounded therapy |
| 07/04/2013 | CA2857339A1 Solid compositions comprising an hcv inhibitor |
| 07/04/2013 | CA2857043A1 Silicone-based composition for skin treatment |
| 07/04/2013 | CA2854281A1 A muscle atrophy inhibitor |
| 07/04/2013 | CA2844878A1 Alpha1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations |
| 07/04/2013 | CA2806706A1 Dexmedetomidine premix formulation |
| 07/03/2013 | EP2609935A1 Switching fluorescent nanoparticle probe and fluorescent particle imaging method using same |
| 07/03/2013 | EP2609933A1 Aqueous composition for ophthalmic administration |
| 07/03/2013 | EP2609924A1 Crosslinked hyaluronic acid composition and self-crosslinking hyaluronic acid particles |
| 07/03/2013 | EP2609916A1 New therapeutic approaches for treating CMT and related disorders |